| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |